Outsourcing-pharma spoke with Peter Ketelaar, VP of bioanalytical labs at AAPS 2010, who predicted the unit's proximity to PRA's US pharmacology facility would improve logistics, sample integrity and turnaround time.
He went on to explain that the unit will increase access to drug industry customers across the US and beyond and added that it will also provide support for PRA's existing bioanalytical lab in the Netherlands.
The addition of a new bionalytical lab is something of a departure for the contract research organisation's (CRO) expansion programme this year.
In April, PRA strengthened its presence in Asia-Pacific with a point of contact in New Zealand and, in February, the firm partnered with Oncopartners and IBPC to boost access to patients in Latin America.